CytoDyn former CEO Nader Pourhassan
FDA slams former CytoDyn CEO's misleading interview in new warning letter
The FDA’s Office of Prescription Drug Promotion recently sent another harsh warning to tiny biotech company CytoDyn for a promo video in which the company’ …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.